Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Balch

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Blood|January 1, 1985
Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulationH W Ziegler-Heitbrock, H Rumpold, D Kraft, et al.
International Journal of Cancer|August 19, 1992
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanomaK Itoh, M A Salmeron, T Morita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanomaJ E Gershenwald, M I Colome, J E Lee, et al.
Cancer|November 1, 1983
Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, AustraliaC M Balch, S J Soong, G W Milton, et al.
Annals of Surgery|December 1, 1982
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, AustraliaC M Balch, S J Soong, G W Milton, et al.
Cancer|November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaA Buzaid, S S Legha, C M Balch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA contentA K El-Naggar, B L Kemp, N Sneige, et al.
Cancer Biotherapy|January 1, 1993
Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid)W Fujimaki, K Itoh, T An, et al.
Annals of Surgery|April 1, 1985
Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patientsM C Trotter, G A Cloud, M Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prognostic value of size of lymph node metastases in patients with cutaneous melanomaA C Buzaid, L A Tinoco, D Jendiroba, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Blood|January 1, 1985
Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulationH W Ziegler-Heitbrock, H Rumpold, D Kraft, et al.
International Journal of Cancer|August 19, 1992
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanomaK Itoh, M A Salmeron, T Morita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanomaJ E Gershenwald, M I Colome, J E Lee, et al.
Cancer|November 1, 1983
Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, AustraliaC M Balch, S J Soong, G W Milton, et al.
Annals of Surgery|December 1, 1982
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, AustraliaC M Balch, S J Soong, G W Milton, et al.
Cancer|November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaA Buzaid, S S Legha, C M Balch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA contentA K El-Naggar, B L Kemp, N Sneige, et al.
Cancer Biotherapy|January 1, 1993
Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid)W Fujimaki, K Itoh, T An, et al.
Annals of Surgery|April 1, 1985
Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patientsM C Trotter, G A Cloud, M Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prognostic value of size of lymph node metastases in patients with cutaneous melanomaA C Buzaid, L A Tinoco, D Jendiroba, et al.
Pageof 23